An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease

Rheumatology International

Volumn 35, Issue 2, 2015, Pages 359-366

  Rodrigues, Igor Kunze ^a   Andrigueti, Michele ^a   de Oliveira Gil, Ione Dilma ^a   de Lucca Schiavon, Leonardo ^a   de Andrade, Kenia Rodrigues ^a   Pereira, Ivanio Alves ^a,b   de Castro, Gláucio Ricardo Werner ^b   Zimmermann, Adriana Fontes ^a   Saporiti, Luciano Nascimento ^b   Bazzo, Maria Luiza ^a   Neves, Fabricio Souza ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Ankylosing spondylitis; Crohn disease; Helicobacter pylori; Inflammatory bowel disease; Saccharomyces cerevisiae; Spondyloarthritis

Indexed keywords

BACTERIUM ANTIBODY; FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANKYLOSING SPONDYLITIS; CROHN DISEASE; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE; SPONDYLOARTHROPATHY; YOUNG ADULT;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; CROHN DISEASE; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE; SPONDYLARTHROPATHIES; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 84939895566     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3088-x     Document Type: Article

References (33)

1. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379–1390
2. Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6:399–405
3. Zeidler H, Calin A, Amor B (2011) A historical perspective of the spondyloarthritis. Curr Opin Rheumatol 23:327–333
4. Thjodleifsson B, Geirsson AJ, Björnsson S, Bjarnason I (2007) A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum 56:2633–2639
5. Laukens D, Georges M, Libioulle C, Sandor C, Mni M, Cruyssen BV, Peeters H, Elewaut D, De Vos M (2010) Evidence for significant overlap between common risk variants for Crohn’s disease and ankylosing spondylitis. PLoS ONE 5:e13795
6. Shivashankar R, Loftus EV Jr, Tremaine WJ, Bongartz T, Harmsen WS, Zinsmeister AR, Matteson EL (2012) Incidence of spondyloarthropathy in patients with Crohn’s disease: a population-based study. J Rheumatol 39:2148–2152
7. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Elewaut D (1995) The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 22:2273–2278
8. Altomonte L, Zoli A, Veneziani A, Mirone L, Santacesaria G, Chiarelli C, Federico F, Massi G, Magaro M (1994) Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies. Clin Rheumatol 13:565–570
9. Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppälä K (1994) High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 37:23–31
10. Simenon G, Van Gossum A, Adler M, Rickaert F, Appelboom T (1990) Macroscopic and microscopic gut lesions in seronegative spondyloarthropathies. J Rheumatol 17:1491–1494
11. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Gyselbrecht L, Elewaut D (1995) The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 22:2279–2284
12. Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, Parratt D (1988) Antibody to Saccharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. Brit Med J 297:1105–1106
13. Prideaux L, De Crux P, Ng SC, Kamm MA (2012) Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 18:1340–1355
14. Andretta M, Vieira TD, Nishiara R, Skare TL (2013) Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis. Rheumatol Int 32:551–554
15. Aydin SZ, Atagunduz P, Temel M, Bicakcigil M, Tasan D, Direskeneli H (2008) Anti-Saccharomycescerevisae antibodies (ASCA) in spondyloarthropathies: a reassessment. Rheumatology 47:142–144
16. Sellin JH, Shah RS (2012) The promise and pitfalls of serologic testing in inflammatory bowel disease. Gastroenterol Clin North Am 41:463–482
17. Hasni S, Ippolito A, Illei GG (2011) Helicobacter pylori and autoimmune diseases. Oral Dis 17:621–627
18. McColl KEL (2010) Helicobacter pylori infection. New Engl J Med 362:1597–1604
19. Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, Yamaoka Y, Berenson GS (2002) Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 359:931–935
20. Malfertheiner P, Megraud F, O’Morain CA et al (2012) Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report. Gut 61:646–664
21. Di Leo V, D’Inca R, Bettini MB, Podswiadek M, Punzi L, Mastropaolo G, Sturniolo GC (2005) Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondyloarthritis. J Rheumatol 32:295–300
22. Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz B-S, Bizzaro N, Tonutti E, Maieron R, Chowers Y, Bar-Meir S, Shoenfeld Y (2009) Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 1173:640–648
23. Väre PO, Heikius B, Silvennoinen JA, Karttunen R, Niemalä SE, Lehtola JK, Karttunen TJ (2001) Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol 36:1295–1300
24. Rudwaleit M, van der Heijde D, Landewé R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783
25. Shinjo SK, Gonçalves R, Gonçalves CR (2006) Measures of clinical assessment in patients with ankylosing spondylitis: review of literature. Rev Bras Reumatol 46:340–346
26. van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818
27. Pfefferle PI, Krämer A (2008) Helicobacter pylori-infection status and childhood living conditions are associated with signs of allergic diseases in an occupational population. Eur J Epidemiol 23:635–640
28. Lee YY, Raj SM, Graham DY (2013) Helicobacter pylori infection – a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter 18:338–346
29. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Tauber C, Müller A (2011) Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 121:3088–3093
30. Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Järbrink M, Müller A (2012) DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 122:1082–1096
31. Kuipers EJ, Peña AS, Pels NFM, Kurz-Pohlmann E, Meuwissen SGM, van Kamp G, Uyterlinde AM, Pals G (1993) Seroconversion for Helicobacter pylori. Lancet 342:328–331
32. Feldman M, Cryer B, Lee E, Peterson WL (1998) Role of seroconversion in confirming cure of Helicobacter pylori infection. JAMA 280:363–365
33. Hoffman IEA, Demetter P, Peeters M, De Vos M, Mielants H, Veys EM, De Keyser F (2003) Anti-Saccharomyces cerevisiae IgA antibodies are raised on ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 62:455–459